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Summary.-A series of patients with a variety of histopathologically confirmed
cancers have been examined using the MOD-MEM test as described by Pritchard
et al. (1973). Despite the closest possible adherence to the experimental protocols
recommended by these authors, no positive reactions to the test were observed in
this series: neither were we able to demonstrate the release of a "macrophage-slow-
ing factor" by a panel of normal donors when challenged with tubercle PPD. We
conclude that the test has no present application to the diagnosis of cancer.
IN 1970, Field and his colleagues intro-
duced a novel method of detecting lym-
phocyte sensitization to specific antigens
(Caspary, Hughes andField, 1970;Caspary
and Field, 1970; Field et al., 1970; Field
and Caspary, 1970). The method resembles
the assay of inhibition of macrophage
migration (David et al., 1964) in that
target macrophages are used to detect a
putative effector substance released by
sensitized lymphocyte populations follow-
ing incubation with the appropriate anti-
gen. The released material brings about a
diminution in the electrophoretic mobility
(EPM) of macrophages (from guinea-pig
peritoneal exudates) when in free sus-
pension. An earlier report (Diengdoh and
Turk, 1968) had described a similar
electrophoretic slowing of peritoneal cells
from tuberculin-sensitized guinea-pigs
after a 60-min in vivo exposure to PPD.
Although first developed and applied by
Field in the area of demyelinating neuro-
logical diseases, at an early stage (Field
and Caspary, 1970) the technique was
extended to the diagnosis of cancer,
following demonstration of sensitivity
towards the encephalitogenic basic protein
of myelin (MBP) among peripheral blood
lymphocytes from patients with proved
malignant disease. Since this first publica-
tion, several othergroups have reported on
the application ofthe test to the detection
ofcancer. Some ofthese, notablyPritchard
et al. (1972), Preece and Light (1974) and
Irmscher et al. (1975) have claimed to
confirm Field and Caspary's original
findings, whereas others (Lewkonia, Kerr
and Irvine, 1974; Crozier et al., 1976) have
failed to demonstrate any clear-cut differ-
ences in response between patients with
malignant disease, individuals with non-
malignant chronic inflammatory condi-
tions, and presumptively normal controls.
From a rather larger series, Rawlins,
Wood and Bagshawe (1976) have con-
cluded that, although there is a high level
of association between a positive MEM
test and clinically evident cancer, the fact
that patients with a number of inflam-
matory and ischaemic diseases also gave
positive responses in the test rendered it
unsuitable for the diagnosis of early
cancer. The test has been modified by
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Pritchard et al. (1973) into a two-stage
procedure which offers experimental ad-
vantages. In a recent publication (1976)
Pritchard and his colleagues have made a
statistical evaluation of the significance of
the occurrenceof 13 "MOD-MEM-positive"
cases among a population of 76 patients in
hospital with non-malignant disease, in
whom the positive test was not explicable
in terms of destruction of nervous paren-
chyma, tissue necrosis, tuberculosis, etc.
They conclude that the age and sex
distribution of these cases is that to be
expected if the MOD-MEM test has the
ability to detect incipient cancer about 16
years before the clinical appearance.
The first publications from Field's
laboratory dealt with sensitivity in cancer
patients to MBP. Later papers (Caspary
and Field, 1971; Carnegie et al., 1973) have
demonstrated a similar or even greater
differential sensitivity to a basic protein
extractable from human cancerous tissue.
This line of approach has been recently
extended by Muller and his colleagues who
have claimed (Muller et al., 1977) that by
testing a patient's lymphocytes against a
panel of "antigens" prepared from a range
of tumours from different anatomic sites
the test may be renderedorganspecific and
thus aid in the localization of occult
cancers.
In his various reviews of the MEM test
(e.g. 1973), Field clearly regards it as
having an immunological basis and reflect-
ing the immune status of the lymphocytes
of the donor with respect to the putative
antigen. Indeed, the test has also been used
to detect a rapid mixed lymphocyte
reaction as an aid to tissue typing (Field,
1972). If the various findings reviewed
above are correct, and their immuno-
logical basis is established, they clearly
have important implications, not only for
the detection of human malignant disease
but also, possibly, for immunotherapeutic
measures to combat it.
We report here a failure to detect
macrophage slowing after exposure to
supernatants from incubations of lympho-
cytes from patients with confirmed malig-
nant disease, with MBP or a peptide
derived from tumour basic protein of
human origin.
METHODS AND MATERIALS
Lymphocytes. Venous blood was obtained
from patients with known malignant disease
at the Royal Marsden Hospital, Fulham Road,
and from healthy volunteers. The patients
(22 males and 20 females aged 23-85)
included examples of mammary, gastro-
intestinal, genitourinary, bronchial and cere-
bral carcinomas, lymphomas and acute
myeloid leukaemia. The normal donors were
laboratory workers of both sexes aged 25-45.
Patients were selected who had received no
chemotherapy or radiotherapy, who were not
immediately post-operative and who had not
received a blood transfusion in the 14 days
before the blood sample was taken. The blood
was either defibrinated or, more usually,
taken into preservative-free heparin (Evans
Medical) at a final concentration of 20 iu/ml;
blood samples prepared by either means were
diluted 1: 1 with Tissue Culture Medium 199
and the lymphocytes separated by centrifu-
gation for 20 min at 400 g on Lymphoprep,
according to the miethod of B0yum (1968).
The lymphocytes harvested from the interface
wNere washed x 3 in TC199 and resuspended
to a final concentration of 106 cells/ml.
Guinea-pigs and macrophage production.-
SPF guinea-pigs have been used throughout
this investigation, obtained sequentially from
Olac Animals, Charles Rivers and Porcellus
Breeding Unit. Originally, SPF Category 4
Star (MRC Accreditation Scheme) guinea-pigs
were used, but when these became unavailable
they wAere replaced by Category 2 Star
animals. The guinea-pigs were kept in a room
isolated from other animals, in filter boxes or
laminar flow cabinets. Bedding, food and
drinking water, to which vitamin C was
added, were all sterile. The bacteriological
status ofthe animals was monitored for up to
6 weeks under this regime, and the results
from this testing demonstrated the efficacy
of the measures employed in preventing
adventitious infections. Further, no symp-
toms of colds or influenza-like infections were
observed in any of the animals during the
course of the investigations.
Exudates were raised by the i.p. injection
of 10 ml liquid paraffin B.P., and the cellsFAILURE TO CONFIRM MEM TEST
harvested 7-16 days after the injection. It is
well known that the size and cellular com-
position of peritoneal exudates varies with
different batches of liquid paraffin. Only oils
producing a consistently high proportion
> 50%o) of droplet-bearing cells were used
in this series of tests. Freshly killed guinea-
pigs were opened along the midline and the
peritoneal cavity was washed out 2-3 tinies
using 80-100 ml TC199, and the cell sus-
pension transferred to glass centrifuge tubes.
The cells were washed x 3 in TC199 and a
suspension prepared of 107 cells/ml. The cells
were exposed to 180 rad of 220 kV X-rays
before use.
Antigens.-The encephalitogenic (MBP)
myelin basic protein was prepared from
human brain following Caspary and Field
(1965) by defatting with chloroform/methanol
and acetone, extracting with HCI at pH 3 0
and chromatographing the crude MBP on
Sephadex G-100 in 10 mM HCI. On
polyacrylamide gel electrophoresis by the
method of Johns (1967) the major band
eoineides in mobility with the major band in
samples of MBP given by Dr J. P. Dickinson
and by Professor A. N. Davison. A minor
band having a mobility equal to that of
globin is present in all 3 samples. This com-
ponent behaves like MBP in gel filtration on
Sephadex G-100, ion exchange chromato-
graphy on CM-cellulose, fractional precipita-
tion with acetone, and 'isoelectric" pre-
cipitation at pH 10-5. The biological activity
of MBP prepared as above was confirmed by
the induction of experimental allergic ence-
phalomyelitis (histopathologically confirmed)
in guinea-pigs with doses down to 10 Hug/
animal administered with Freund's complete
adjuvant intradermally over the sternum.
For the preparation of "cancer basic
protein" (Caspary and Field, 1971; Carnegie
et al., 1973) a basic protein, said to be present
on the external surface of the cell membrane
of all cancer cells, which behaves similarly in
the MEM test to MBP (Dickinson and
Caspary, 1973), various surgical and post-
mortem human tumour specimens, HeLa
cells, and crude membrane preparations from
tumours or HeLa cells, were subjected to
defatting and acid extraction as in the
preparation of MBP. On gel electrophoresis,
most of these extracts were found to have, as
their major components, proteins whose
banding patterns were identical to those of
human histones; no major component, and
no minor consistent component, with a
mobility close to that of MBP was observed.
These preparations did not cause macrophage
slowing in the MEM test with lymphocytes
from normal individuals or cancer patients.
MBP was used in the MEM test at a final
concentration of 33 jug/ml. We also used a
peptide derived from cancer basic protein of
human tumour tissue prepared by Dr J. P.
Dickinson, which was used at an unknowvin
but reputedly effective concentration. PPD
was obtained from the Central Veterinary
Laboratory, Weybridge.
Glassuare. All glassware used was washed
strictly according to a protocol recommended
by Dr Pritchard. After soaking overnight in
10 ° Chloros the glassware was rinsed and
transferred to 1% liquid Labrite for a further
24 h before being rinsed in 10 changes each of
hot tapwater, cold tapwater and distilled
water; double glass distilled water was used
for the last 2 rinses. None ofthe glassware was
siliconized.
Medium.-TC199 writh Hanks' salts and
bicarbonate-buffered was made up from
Gibco-Biocult powdered medium using
double-glass-distilled water. The conduc-
tivity of each batch was checked using an
LKB Conductolyzer and, if necessary, ad-
justed to provide an electrophoresis medium
of constant electrical properties, specific
resistance 67-3 Q/cm.
MOD-MEM methodology.-The MOD-
MEM method of Pritchard et al. (1973) was
used for all samples tested during this series.
'Macrophage slowing factor" (MSF) was
prepared by incubating 106 lymphocytes
suspended in 2 ml TC199 with antigen at the
appropriate concentration for 90 min at room
temperature. Supernatants from these, and
from control tubes set up without antigen,
were either used immediately for a second-
stage incubation with guinea-pig macrophages
or stored at -40°C for subsequent examina-
ton. Samples for electrophoresis wereprepared
by taking 107 peritoneal exudate cells in 1 ml
TC199 and incubating with 2-ml aliquots of
lymphocyte supernatants for 90 min at 37°C.
The samples were allowed to cool to about
25°C before being introduced slowly into the
eytopherometer chamber. Samples were ran-
domized by an uninvolved colleague: on most
occasions duplicate series w%ere set up and
examined by at least 2 operators.
Measuring technique. Determinations of
EPM were made in a Zeiss Cytopherometer.
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Macrophages of about 16 ,um diameter con-
taining 2 or 3 ingested oil droplets were
selected for timing (Shenton, Hughes and
Field, 1973). Percentage slowing was calcu-
lated using the formula (Te- T)/T, x 100
where T, is the mean time for cells in the
control sample and Te that for cells in the test
sample (Caspary and Field, 1971). The
significance of changes in mobility wvas
assessed by means of Student's t test.
RESULTS
The accuracy and reliability of cell
electrophoretic measurements can only be
compared from instrument to instrument,
worker to worker and laboratory to
laboratory by consideration of absolute
electrophoretic mobilities, although in
comparative studies on a single instrument,
it is perfectly adequate to consider only
the mean times of migration over a fixed
distance under standard conditions. The
absolute mobilities of untreated target
macrophages fulfilling the criteria of
Shenton et al. (1973) determined on a
number ofoccasions throughout the course
ofthese investigations are listed in Table I.
The table includes determinations by 2
observers on 2 instruments.
TABLE.-The Absolute Mobilities of Un-
treated Guinea-pig Peritoneal Macro-
phages in TC 199 Determined on 10
Separate Occasions
Mobility±s.d.
x 10-4cm2/sec V
-0 887±0 038
-0-884±0 034
-0 859±0 040
-0 898+0 047
-0 882±0 041
-0 898±0 023
-0 8704-+0 046
-0 873±0 035
-0-875±0-032
-0-898+0-033
Coefficienit of
variation
4-3%
:3 -8%
4-7%
5-2%
4 6%
2-6%
5 *3%
4 0%
:3-7%
3.870
Fig. 1 is a frequency histogram of the
percentage slowing found in a group of 27
normal controls exposed to MBP or cancer
basic peptide. Fig. 2 is a similarly con-
structed histogram ofslowings observed in
the patient group. Results obtained with
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IIe. 1. Histogram showing macrophage
percentage slow%ving in the MOD-MEM test
for a group of 22 normal donors using either
MBP or tumotur-clerived peptide as antigen.
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FIG. 2. Histogram showing macrophage
percentage slowing in the MOD-MEM test
for a group of 42 patients with provecl
malignancies using MBP or tumour-
dlerived peptide as antigen.
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FIG. 3.-Histogram showing macrophage
percentage slowing in the MOD-MEM test
for a group of 14 normal donors using PPD
as antigen.
MBP and cancer basic peptide are com-
bined in this figure since there was no
apparent distinction to be drawn between
the results obtained with these alternate
"antigens". Fourpatients were tested with
both antigens and both results are in-
cluded here. Fig. 3 shows the results from
testing 14 normal donors with PPD. The
histograms show no generalized slowing of
macrophages under any of the experi-
mental conditions, in particular when
lymphocytes from cancer patients were
exposed to MBP or cancer basic peptide.
DISCUSSION
We have failed (with 2 exceptions
mentioned below) to show any significant
reaction in a series of 42 patients with
proved malignant disease when investi-
gated using the MOD-MEM test as
described by Pritchard et al. (1973).
Qualitatively, however, our results differ
from those of other authors who have
reported unfavourably upon the test
(Lewkonia et al., 1974; Crozier et al., 1976;
Rawlins et al., 1976). These other workers
have generally reported a wide scatter of
results from both normal and patient
groups, with considerable overlap between
groupsleading to both "false-positive" and
"false-negative" results. In contrast, our
results show comparatively small scatter
and offer no evidence for the existence of
a "macrophage slowing factor" in the
supernatants tested.
A number of authors, when discussing
the MEM test (Lewkonia et al., 1974;
Field and Shenton, 1975; Crozier et al.,
1976; Fraser and Hancock, 1976), have
commented upon the technical difficulties
surrounding successful operation of the
Zeiss Cytopherometer. One of the present
authors (J.A.F.) has had some 15 years'
experience of cell electrophoretic tech-
niques and has been familiar with the
Zeiss instrument since its introduction in
1964. The present series of patients,
selected using the strict criteria set out in
the Materials section, was only undertaken
after about a year's experience of the
technique and investigation of various
experimental aspects ofthe test system by
two other authors. The values listed in the
Table demonstrate the consistency of
electrophoretic measurement which can be
achieved after proper familiarization with
the instrument. Ithas longbeenrecognized
that well washed erythrocytes are electro-
phoretically a highly homogeneous popu-
lation ofcells andtheyhave been generally
used as a standard for checking the
calibration of cell electrophoresis instru-
ments. The coefficient ofvariation of such
populations, calculated from measure-
ments on samples of 10-20 cells is of the
order of 2.5% (Seaman and Heard, 1960).
This probably represents, as a combina-
tion of biological variability on the one
hand and uncertainty in the physical
determination on the other, the limit of
resolution of the cell electrophoretic
method. The greater scatter of the target
macrophage populations recorded in the
Table presumably reflects, therefore,
greater biological variation in the popula-
tion under study, and accords with other
published data on nucleated cells (see
Forrester, 1975). Indeed, one can only
achieve this degree of precision with
peritoneal exudate cells if the morpho-
logical criteria laid down by Shenton et al.
(1973) are rigidly adhered to: if an
I I
I I I
-
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unselected series ofmeasurements is made,
embracing all the cellular entities present
in a peritoneal exudate, then a coefficient
of variation in excess of 1500 is not
uncommon. However, with the degree of
precision here demonstrated, slowing of
the magnitude described for a positive
reaction in the MEM test (15-20%) would
be readily detectable and highly signi-
ficant. Further, the mean absolute mobi-
lity, - 0 88 X 10-4cm2/sec V, agrees well
with values obtained by other workers
using the same suspension medium (Preece
and Light, 1974; Pritchard, personal
communication). It is thus clear that the
technique as established in this laboratory
is quite capable of reliably detecting the
electrophoretic slowing described by Field
and Caspary.
Occasionally, in untreated cell popula-
tions, macrophages are found which,
although fulfilling the morphological
criteria set out by Shenton et al. (1973),
show a substantially ( > 1]2%) lower
electrophoretic mobility than the expected
mean value. In order to get round this
problem Pritchard et al. (1972) recorded
their results in 2 columns, effectively
segregating faster and slower cell popula-
tions at an arbitrary cut-off point, until
one or other column contained 10 values.
The values in that column were then
treated statistically to yield parameters
which were attributed to the population
as a whole. In a series of 38 samples of 10
macrophages, each from untreated popu-
lations, we observed a total of 10 such cells
which were more than 12% slower than
the expected mean, i.e. a frequency of
2.6%. Because of this low rate of occur-
rence ofslow cells in our exudates we have
not adopted the 2-column system, but
have simply recorded the first 10 cells
which fulfilled the morphological criteria
for responsive cells. In Fig. 2 the 2
samples showing slowing of 500 and 70 at
the right of the frequency histogram are
significantly slowed (P < 0.01). Both sam-
ples contain 2 cells slow enough to have
been excluded using the 2-column tech-
nique, and which are responsible for the
significant shift in the mean values. If
"slow" cells exist at the level of 2.6% in
all exudates, the expectation is that out of
46 pairs of samples each containing 10
cells, 1 7 would have one sample of all
"normal" mobility and one containing 2
"slow" cells and the remainder normal.
Thus, the 2 aberrant results could have
arisen from chance alone. Certainly, since
never more than 2 slow cells were observed
in any sample, use of the 2-column tech-
nique would have made no difference to
the final outcome of our observations
other than to reduce the scatter in the
frequency histograms.
The details of the methods used in the
experiments described in this paper were
arrived at after considerable personal
"trial and error" investigation and exten-
sive discussion and collaboration with
Dr J. A. V. Pritchard. They represent as
nearly as possible an exact replication of
the methods used in Cardiff, the major
cause of variation lying in the source of
the guinea-pigs used to provide the
peritoneal exudates. However, Dr Prit-
chard was able to let us have a group of
mature guinea-pigs from his colony to
compare with our usual stocks. In a series
of experiments we found no significant
difference in cellular composition of exu-
dates produced in these animals, identical
electrophoretic mobility ofthemacrophage
component, and, further, we obtained
uniformly negative results when these cells
were used to test supernatants, from both
cancer patients and multiple sclerosis
sufferers, generated using MBP as "anti-
gen". Taken together with the SPF status
of the animals used for the bulk of this
work and the techniques of husbandry
employed, this comparison ofthe 2 sources
of animals gave us confidence that the cell
populations used fulfilled the necessary
conditions, both morphological and
physico-chemical, to be responsive in the
test. In other experiments, recognized
methods of reducing cell electrophoretic
mobility (e.g. treatment with bacterial
neuraminidase or with polycations) were
applied to this population of cells to checkFAILURE TO CONFIRM MEM TEST 543
the operators' ability to detect and
quantitate electrophoretic slowing. Ex-
perimental conditions which give rise to
slowing of between 10 and 1500 were
regularly and unfailingly identified from
random series.
WVe must therefore conclude that in our
hands treatment of isolated blood lym-
phocytes from cancer patients with MBP
or other materials does not result in the
release of a "macrophage-slowing factor".
We should mention here that we have
been unable to demonstrate the slowing
phenomenon in other systems, including
multiple sclerosis using MBP as 'antigen'
(Smith and Forrester, in preparation)
and in tuberculin-sensitized guinea-pigs
using PPD. Our failure to observe slowing
when lymphocytes from normal human
donors are challenged with PPD, upon
which Field has laid much stress (vide
Field and Shenton, 1975), accords with
the experience of Pritchard (personal
communication). In anothersystem, Fraser
and Hancock (1976) have been unable to
confirm the application ofthe MEM test to
the laboratory diagnosis of scrapie in
sheep.
It is clear that it is not possible to
reconcile the results described here with
reports from other laboratories confirming
the validity of the MEM test in cancer. It
may be that there is some flaw in our
methods of cell handling which has
vitiated ouir attempts to reproduce the
test. If this is so then it has withstood a
most careful scrutiny of our techniques in
conjunction with Dr J. A. V. Pritchard.
We can thus only reinforce the views of
those authors who have concluded that
the MEM test in its present form has no
place in the diagnosis of malignancy.
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